Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-1993 | 03-1992 | 03-1991 | 03-1990 | 03-1989 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 914 | 114 | 243 | 150 | 201 |
| Receivables | 995 | 510 | 211 | 116 | 181 |
| Inventories | 407 | 419 | 154 | 112 | 45 |
| Other current assets | 83 | 71 | 40 | 17 | 12 |
| TOTAL | $2,398 | $1,115 | $647 | $395 | $439 |
| Non-Current Assets | |||||
| PPE Net | 206 | 59 | 8 | 7 | 8 |
| Other Non-Current Assets | 31 | 19 | 4 | 3 | 3 |
| TOTAL | $237 | $78 | $11 | $10 | $11 |
| Total Assets | $2,635 | $1,193 | $658 | $405 | $450 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 148 | 54 | 55 | 20 | 34 |
| Accrued Expenses | 232 | 188 | 136 | 47 | 72 |
| Other current liabilities | 0 | 129 | 269 | 2 | 2 |
| TOTAL | $455 | $414 | $460 | $69 | $108 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $455 | $414 | $460 | $69 | $108 |
| Shareholders' Equity | |||||
| Common Shares | 5,021 | 4,846 | 4,838 | 4,728 | 4,494 |
| Retained earnings | -2,841 | -4,077 | -4,649 | -4,499 | -4,369 |
| Other shareholders' equity | 0 | 10 | 10 | 107 | 218 |
| TOTAL | $2,180 | $779 | $198 | $336 | $342 |
| Total Liabilities And Equity | $2,635 | $1,193 | $658 | $405 | $450 |